CpG is synthetic ODN with unmethylated CG dinucleotides within particular sequence contexts[3], CpG ODN has been used in clinical trials as a vaccine adjuvant for immunotherapy of cancer since it can mimic microbial DNA and activate immune system through the binding of TLR9. The gene discussed is TLR9; the disease is cancer.